» Articles » PMID: 30822589

Risk Factors for Restenosis After Carotid Revascularization: A Meta-Analysis of Hazard Ratios

Overview
Journal World Neurosurg
Publisher Elsevier
Date 2019 Mar 2
PMID 30822589
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Carotid artery restenosis after carotid endarterectomy (CEA) or carotid artery stenting (CAS) will occur in 3%-30% of cases. Restenosis can lead to more frequent clinical and imaging monitoring and the potential for reoperation. We sought to define the demographic, clinical, and radiographic characteristics that influence the restenosis risk after carotid revascularization.

Methods: The present study was performed in accordance with the PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines. A random effects model meta-analysis of hazard ratios (HRs) was conducted.

Results: Eighteen studies with 17,106 patients were included. Diabetes (HR, 1.68; 95% confidence interval [CI], 1.00-2.83; I, 76.7%), dyslipidemia (HR, 1.77; 95% CI, 1.08-2.91; I, 22.5%), female gender (HR, 1.50; 95% CI, 1.14-1.98, I, 0%), chronic kidney disease (HR, 4.15; 95% CI, 1.69-10.19; I, 44.5%), hypertension (HR, 1.99; 95% CI, 1.07-3.72; I, 68%), smoking (HR, 1.65; 95% CI, 1.15-2.37; I, 54.3%), and pretreatment stenosis >70% (HR, 1.04; 95% CI, 1.0-1.08; I, 0%) showed a statistically significant increase in restenosis risk after carotid revascularization. Subgroup analyses of CEA and CAS showed that female gender and smoking status were significantly associated with recurrent stenosis after CEA but not after CAS. In contrast, hypertension was associated with restenosis after CAS but not after CEA. Patch endarterectomy (HR, 0.33; 95% CI, 0.22-0.50; I, 0%) and symptomatic status at presentation in the CAS group (HR, 0.61; 95% CI, 0.41-0.90; I, 0%) were associated with a decreased risk of restenosis. Antiplatelet use and coronary artery disease were not associated with restenosis risk.

Conclusions: Diabetes, dyslipidemia, female gender, renal failure, hypertension, and smoking were associated with an increased risk of restenosis, and patch endarterectomy and symptomatic status at presentation were associated with a decreased risk of carotid restenosis. Both female gender and current smoking status were only associated with recurrent stenosis after CEA, and hypertension was only associated with restenosis after CAS.

Citing Articles

Advancements in the Treatment of Atherosclerosis: From Conventional Therapies to Cutting-Edge Innovations.

Liu Y, Lu K, Zhang R, Hu D, Yang Z, Zeng J ACS Pharmacol Transl Sci. 2024; 7(12):3804-3826.

PMID: 39698263 PMC: 11651175. DOI: 10.1021/acsptsci.4c00574.


Risk factors of in-stent restenosis after carotid angioplasty and stenting: long-term follow-up study.

Park S, Kim B, Choi H, Chang D, Woo H, Heo S Front Neurol. 2024; 15:1411045.

PMID: 39175764 PMC: 11340531. DOI: 10.3389/fneur.2024.1411045.


Subclavian-Carotid Bypass as a Solution to Recurrent Carotid Artery Stenosis Post Endarterectomy and Transfemoral Stenting.

Balakrishnan P, Anderson J, Arcand C, Krantz M, Kitchen J Cureus. 2024; 16(6):e63087.

PMID: 39055438 PMC: 11270155. DOI: 10.7759/cureus.63087.


Associations of genetic markers of diabetes mellitus with carotid atherosclerosis: a community-based case-control study.

Wu T, Chou C, Cheng C, Lu S, Wu Y, Wang L Cardiovasc Diabetol. 2023; 22(1):51.

PMID: 36894991 PMC: 9999522. DOI: 10.1186/s12933-023-01787-7.


Long-term outcomes of carotid artery stenting in patients with carotid artery stenosis: A single-center 14-year retrospective analysis.

Kang B, Mann Yoon S, Oh J, Oh H, Ahn J, Yong Yun G J Cerebrovasc Endovasc Neurosurg. 2023; 25(2):160-174.

PMID: 36718046 PMC: 10318231. DOI: 10.7461/jcen.2023.E2022.07.007.